Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Weekly Wrap 12 September

Bell Direct
September 12, 2025

Morning Bell 11 September

Bell Direct
September 11, 2025

Morning Bell 10 September

Bell Direct
September 10, 2025

Morning Bell 9 September

Bell Direct
September 9, 2025

Morning Bell 8 September

Bell Direct
September 8, 2025

Weekly Wrap 5 September

Bell Direct
September 5, 2025

Morning Bell 4 September

Bell Direct
September 4, 2025

Morning Bell 3 September

Bell Direct
September 3, 2025

Morning Bell 2 September

Bell Direct
September 2, 2025

Morning Bell 1 September

Bell Direct
September 1, 2025

Weekly Wrap 29 August

Bell Direct
August 29, 2025

Morning Bell 28 August

Bell Direct
August 28, 2025